Growth failure as a prognostic indicator for progression to acquired immunodeficiency syndrome in children with hemophilia.

V. Scleroderma in childhood. Arthritis Rheum 1977;20:34350. 3. Dilley J J, Perry HO. Bilateral linear scleroderma en coup de sabre. Arch Dermatol 1968;97:688-9. 4. Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austin KF. Dermatology in general medicine. 3rd ed. New York: McGraw-Hill, 1987:1842-3. 5. Fries R. Uber die hemiatrophia faciei. Klin Med (Wien) 1964;19:70-6. 6. Woo TY, Rasmussen JE. Juvenile linear scleroderma associated with serologic abnormalities. Arch Dermatol 1985; 121:1403-5. 7. Tuffanelli DL, Marmalzat WL, Dorsey CS. Linear scleroderma with facial hemiatrophy: report of three cases associated with collagen-vascular disease. Dermatologica 1966; 132:51-8. 8. Hanson V, Drexler E, and Kornreich H. Rheumatoid factor (anti-gamma-globulins) in children with focal scleroderma. Pediatrics 1974;53:945-7. 9. Falanga V, Medsger TA Jr, Reiclhin M. Antinuclear and anti-single-stranded DNA antibodies in morphea and generalized morphea. Arch Dermatol 1987;123:350-3. 10. Aver'ianov luN, Uvarova NN, Tskhovrebov TM, Maksimenko IM. Sindrom gemiatrofii litsa, ochagovoi sklerodermii i fokal'nykh epilepticheskikh pripadkov v sochetanii s dvustoronnim uveitom. Zh Nevropatol Psikhiatr (Rus) 1989;89:26-8. 11. Jablonska S, Rodnan GP. Localized forms of scleroderma. Clin Rheum Dis 1979;5:215-41. 12. Jablonska S. Scleroderma and pseudoscleroderma. 2nd ed. Warsaw: Polish Medical Publishers, 1975. 13. Rosenbaum JT, Nozik RA. Uveitis: many diseases, one diagnosis. Am J Med 1985;79:545-7. 14. Knox DL. Uveitis. Pediatr Clin North Am 1987;34:1467-85. 15. Wartenberg R. Progressive facial hemiatrophy. Arch Neurol Psychiatry 1945;54:75-96. 16. Simon HE, Kaye B. Progressive hemiatrophy of the face. Arch Neurol Psychiatry 1945;53:437-8. 17. Miller MT, Sloane H, Goldberg MF, Grisolano J, Frenkel M, Mafee MF. Progressive hemifacial atrophy (Parry-Romberg disease). J Pediatr Ophthalmol Strabismus t987;24:27-36.